| For: | Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artif Intell Gastroenterol 2021; 2(1): 1-9 [DOI: 10.35712/aig.v2.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2644-3236/full/v2/i1/1.htm |
| Number | Citing Articles |
| 1 |
Abhishek Kumar Sahu, Rosaleen Sahoo, Parameswar Sahu, Sundeep Singh Saluja, Siddharth Srivastava. Natural Compounds and Alternative Therapies for Hepatitis. 2026; doi: 10.1002/9781394466573.ch13
|
| 2 |
Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroaki Okamoto, Shuji Terai, Cole D. Cwiklowski, Kalyan C. Nagulapalli Venkata. Targeting the 3C Protease of Hepatitis A Virus Subgenotype IB: Virtual Screening and Identification of Potent Lead Candidates. Microorganisms 2026; 14(9) doi: 10.3390/microorganisms14091987
|
| 3 |
Reina Sasaki-Tanaka, Tatsuo Kanda, Takeshi Yokoo, Hiroyuki Abe, Kazunao Hayashi, Akira Sakamaki, Hiroteru Kamimura, Shuji Terai. Hepatitis A and E Viruses Are Important Agents of Acute Severe Hepatitis in Asia: A Narrative Review. Pathogens 2025; 14(5) doi: 10.3390/pathogens14050454
|